APA (7th ed.) Citation

Burmeister, B. H., Henderson, M. A., Ainslie, J., Fisher, R., Di Iulio, J., Smithers, B. M., . . . Thompson, J. F. (2012). Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: A randomised trial. Lancet Oncology, 13(6), 589. https://doi.org/10.1016/S1470-2045(12)70138-9

Chicago Style (17th ed.) Citation

Burmeister, Bryan H., et al. "Adjuvant Radiotherapy Versus Observation Alone for Patients at Risk of Lymph-node Field Relapse After Therapeutic Lymphadenectomy for Melanoma: A Randomised Trial." Lancet Oncology 13, no. 6 (2012): 589. https://doi.org/10.1016/S1470-2045(12)70138-9.

MLA (9th ed.) Citation

Burmeister, Bryan H., et al. "Adjuvant Radiotherapy Versus Observation Alone for Patients at Risk of Lymph-node Field Relapse After Therapeutic Lymphadenectomy for Melanoma: A Randomised Trial." Lancet Oncology, vol. 13, no. 6, 2012, p. 589, https://doi.org/10.1016/S1470-2045(12)70138-9.